De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes

Sally Killick; Aimee Jackson; Helen C. Coulthard; Christina Yap; Emma Das-Gupta; Dudley J. Pennell; John Porter; David Bowen; Dominic Culligan

doi:10.1111/bjh.16669

De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes

Sally Killick, Aimee Jackson, Helen C. Coulthard, Christina Yap, Emma Das-Gupta, Dudley J. Pennell, John Porter, David Bowen, Dominic Culligan

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	e237-e240
Journal	British Journal of Haematology
Volume	189
Issue number	6
DOIs	https://doi.org/10.1111/bjh.16669
Publication status	Published - Jun 1 2020
Externally published	Yes

ASJC Scopus Subject Areas

Hematology

Access to Document

10.1111/bjh.16669

Cite this

Killick, S., Jackson, A., Coulthard, H. C., Yap, C., Das-Gupta, E., Pennell, D. J., Porter, J., Bowen, D., & Culligan, D. (2020). De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes. British Journal of Haematology, 189(6), e237-e240. https://doi.org/10.1111/bjh.16669

De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes. / Killick, Sally; Jackson, Aimee; Coulthard, Helen C. et al.
In: British Journal of Haematology, Vol. 189, No. 6, 01.06.2020, p. e237-e240.

Research output: Contribution to journal › Letter › peer-review

Killick, S, Jackson, A, Coulthard, HC, Yap, C, Das-Gupta, E, Pennell, DJ, Porter, J, Bowen, D & Culligan, D 2020, 'De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes', British Journal of Haematology, vol. 189, no. 6, pp. e237-e240. https://doi.org/10.1111/bjh.16669

@article{cf2e2a2aad8d47f2bbfeab32f98d7a5b,

title = "De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes",

author = "Sally Killick and Aimee Jackson and Coulthard, {Helen C.} and Christina Yap and Emma Das-Gupta and Pennell, {Dudley J.} and John Porter and David Bowen and Dominic Culligan",

year = "2020",

month = jun,

day = "1",

doi = "10.1111/bjh.16669",

language = "English",

volume = "189",

pages = "e237--e240",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - De-Iron

T2 - a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes

AU - Killick, Sally

AU - Jackson, Aimee

AU - Coulthard, Helen C.

AU - Yap, Christina

AU - Das-Gupta, Emma

AU - Pennell, Dudley J.

AU - Porter, John

AU - Bowen, David

AU - Culligan, Dominic

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85084697596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084697596&partnerID=8YFLogxK

U2 - 10.1111/bjh.16669

DO - 10.1111/bjh.16669

M3 - Letter

C2 - 32342485

AN - SCOPUS:85084697596

SN - 0007-1048

VL - 189

SP - e237-e240

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 6

ER -

De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this